Cynthia Forsthoff
Long Beach, CANPI 1841250719
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations.
Across 92 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$284
- Pfizer$175
- AstraZeneca$150
- E.r. Squibb & Sons, L.L.C.$146
- Merck$127
- Amgen$107
- plus $737 from 19 others
What the payments were for
- Food & beverage$1,67597%
- Education$513%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 15 | $284 |
| Pfizer | 13 | $175 |
| AstraZeneca | 7 | $150 |
| E.r. Squibb & Sons, L.L.C. | 12 | $146 |
| Merck | 7 | $127 |
| Amgen | 4 | $107 |
| Johnson & Johnson | 3 | $88 |
| Incyte Corporation | 4 | $77 |
| Exelixis Inc. | 3 | $73 |
| Genentech USA, Inc. | 3 | $63 |
| Bristol Myers Squibb | 3 | $62 |
| Gilead | 2 | $45 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $40 |
| AbbVie | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Boehringer Ingelheim | 1 | $31 |
| Sanofi | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Seagen Inc. | 1 | $24 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Tesaro, Inc. | 1 | $18 |
| EMD Serono, Inc. | 1 | $18 |
| Dova Pharmaceuticals | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Clovis Oncology, Inc. | 1 | $14 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.